Literature DB >> 21979797

Functional characterization of a genetic polymorphism in the promoter of the ESR2 gene.

Santosh Philips1, Alexandra Richter, Steffi Oesterreich, James M Rae, David A Flockhart, Narayanan B Perumal, Todd C Skaar.   

Abstract

The ESR2 gene encodes the estrogen receptor beta protein. Several studies have shown that genetic variants in the ESR2 gene are associated with a variety of clinical phenotypes. However, very little is known about the functional significance of ESR2 genetic variants. We used a bioinformatics approach to identify regions of the ESR2 promoter that is evolutionarily conserved across the genomes of several species. We resequenced 1.6 kb of the ESR2 gene which included 0.8 kb of the promoter, 0.3 kb of exon ON, and 0.5 kb of the following intron. We identified five single-nucleotide polymorphisms (SNPs) in the ESR2 promoter and one SNP in the intron. Phase analysis indicated that the SNPs likely exist in 11 different haplotypes. Three of the SNPs (rs8008187, rs3829768, rs35036378) were predicted to alter transcription factor binding sites in the ESR2 promoter. All three were detected only in African American subjects. The rs35036378 SNP was in the TATA box and was highly conserved across species. ESR2 promoter reporter assays in LNCaP and SKBR3 cell lines showed that the variant construct containing the rs35036378 SNP allele had approximately 50% less activity relative to the wild-type construct. We conclude that the rs35036378 SNP appears to cause a reduced promoter activity of the ESR2 gene.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21979797      PMCID: PMC3402208          DOI: 10.1007/s12672-011-0086-2

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  28 in total

1.  Interpretation of association signals and identification of causal variants from genome-wide association studies.

Authors:  Kai Wang; Samuel P Dickson; Catherine A Stolle; Ian D Krantz; David B Goldstein; Hakon Hakonarson
Journal:  Am J Hum Genet       Date:  2010-04-29       Impact factor: 11.025

Review 2.  ERbeta in CNS: new roles in development and function.

Authors:  Xiaotang Fan; Haiwei Xu; Margaret Warner; Jan-Ake Gustafsson
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 3.  The dual, opposing roles of estrogen in the prostate.

Authors:  Stuart J Ellem; Gail P Risbridger
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

Review 4.  The importance of ERbeta signalling in the ovary.

Authors:  Ann E Drummond; Peter J Fuller
Journal:  J Endocrinol       Date:  2009-12-17       Impact factor: 4.286

5.  Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients.

Authors:  Silvana Borges; Zeruesenay Desta; Yan Jin; Azzouz Faouzi; Jason D Robarge; Sanosh Philips; Santosh Philip; Anne Nguyen; Vered Stearns; Daniel Hayes; James M Rae; Todd C Skaar; David A Flockhart; Lang Li
Journal:  J Clin Pharmacol       Date:  2010-01-15       Impact factor: 3.126

6.  Rare variants create synthetic genome-wide associations.

Authors:  Samuel P Dickson; Kai Wang; Ian Krantz; Hakon Hakonarson; David B Goldstein
Journal:  PLoS Biol       Date:  2010-01-26       Impact factor: 8.029

7.  Association between ESR2 genetic variants and risk of myocardial infarction.

Authors:  Sophie Domingues-Montanari; Isaac Subirana; Marta Tomás; Jaume Marrugat; Mariano Sentí
Journal:  Clin Chem       Date:  2008-05-16       Impact factor: 8.327

8.  Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma.

Authors:  Fumihiko Suzuki; Jun-Ichi Akahira; Ikumi Miura; Takashi Suzuki; Kiyoshi Ito; Shin-Ichi Hayashi; Hironobu Sasano; Nobuo Yaegashi
Journal:  Cancer Sci       Date:  2008-11-17       Impact factor: 6.716

9.  Estrogen receptor polymorphisms and the risk of endometrial cancer.

Authors:  K A Ashton; A Proietto; G Otton; I Symonds; M McEvoy; J Attia; M Gilbert; U Hamann; R J Scott
Journal:  BJOG       Date:  2009-05-11       Impact factor: 6.531

10.  Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy.

Authors:  Yan Jin; Daniel F Hayes; Lang Li; Jason D Robarge; Todd C Skaar; Santosh Philips; Anne Nguyen; Anne Schott; Jill Hayden; Suzanne Lemler; Anna Maria Storniolo; David A Flockhart; Vered Stearns
Journal:  J Clin Oncol       Date:  2008-11-17       Impact factor: 44.544

View more
  9 in total

1.  Candidate SNP markers of aggressiveness-related complications and comorbidities of genetic diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters.

Authors:  Irina V Chadaeva; Mikhail P Ponomarenko; Dmitry A Rasskazov; Ekaterina B Sharypova; Elena V Kashina; Marina Yu Matveeva; Tatjana V Arshinova; Petr M Ponomarenko; Olga V Arkova; Natalia P Bondar; Ludmila K Savinkova; Nikolay A Kolchanov
Journal:  BMC Genomics       Date:  2016-12-28       Impact factor: 3.969

2.  Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women.

Authors:  Michael N Passarelli; Amanda I Phipps; John D Potter; Karen W Makar; Anna E Coghill; Karen J Wernli; Emily White; Andrew T Chan; Carolyn M Hutter; Ulrike Peters; Polly A Newcomb
Journal:  Cancer Res       Date:  2012-11-13       Impact factor: 12.701

3.  Chicken mannose-binding lectin (MBL) gene variants with influence on MBL serum concentrations.

Authors:  Rikke M Kjærup; Liselotte R Norup; Karsten Skjødt; Tina S Dalgaard; Helle R Juul-Madsen
Journal:  Immunogenetics       Date:  2013-03-02       Impact factor: 2.846

4.  How to Use SNP_TATA_Comparator to Find a Significant Change in Gene Expression Caused by the Regulatory SNP of This Gene's Promoter via a Change in Affinity of the TATA-Binding Protein for This Promoter.

Authors:  Mikhail Ponomarenko; Dmitry Rasskazov; Olga Arkova; Petr Ponomarenko; Valentin Suslov; Ludmila Savinkova; Nikolay Kolchanov
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

5.  Obesity-related known and candidate SNP markers can significantly change affinity of TATA-binding protein for human gene promoters.

Authors:  Olga V Arkova; Mikhail P Ponomarenko; Dmitry A Rasskazov; Irina A Drachkova; Tatjana V Arshinova; Petr M Ponomarenko; Ludmila K Savinkova; Nikolay A Kolchanov
Journal:  BMC Genomics       Date:  2015-12-16       Impact factor: 3.969

6.  Candidate SNP Markers of Chronopathologies Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.

Authors:  Petr Ponomarenko; Dmitry Rasskazov; Valentin Suslov; Ekaterina Sharypova; Ludmila Savinkova; Olga Podkolodnaya; Nikolay L Podkolodny; Natalya N Tverdokhleb; Irina Chadaeva; Mikhail Ponomarenko; Nikolay Kolchanov
Journal:  Biomed Res Int       Date:  2016-08-22       Impact factor: 3.411

7.  Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters.

Authors:  Irina V Chadaeva; Petr M Ponomarenko; Dmitry A Rasskazov; Ekaterina B Sharypova; Elena V Kashina; Dmitry A Zhechev; Irina A Drachkova; Olga V Arkova; Ludmila K Savinkova; Mikhail P Ponomarenko; Nikolay A Kolchanov; Ludmila V Osadchuk; Alexandr V Osadchuk
Journal:  BMC Genomics       Date:  2018-02-09       Impact factor: 3.969

8.  Candidate SNP Markers of Atherogenesis Significantly Shifting the Affinity of TATA-Binding Protein for Human Gene Promoters show stabilizing Natural Selection as a Sum of Neutral Drift Accelerating Atherogenesis and Directional Natural Selection Slowing It.

Authors:  Mikhail Ponomarenko; Dmitry Rasskazov; Irina Chadaeva; Ekaterina Sharypova; Irina Drachkova; Dmitry Oshchepkov; Petr Ponomarenko; Ludmila Savinkova; Evgeniya Oshchepkova; Maria Nazarenko; Nikolay Kolchanov
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

Review 9.  Topics in transcriptional control of lipid metabolism: from transcription factors to gene-promoter polymorphisms.

Authors:  Werner G Bergen; Derris D Burnett
Journal:  J Genomics       Date:  2013-10-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.